Skip to main content
PloS one
Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction.
Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study.
Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter.
Increases in myocardial workload induced by rapid atrial pacing trigger alterations in global metabolism.
Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.
Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress.
Pleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variants.
An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors.
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.
Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction.
